Rousseau Raphael 4
4 · Gritstone Oncology, Inc. · Filed Aug 23, 2019
Insider Transaction Report
Form 4
Rousseau Raphael
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2019-08-21$0.76/sh+10,000$7,600→ 10,000 total - Sale
Common Stock
2019-08-21$10.76/sh−10,000$107,631→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2019-08-21−10,000→ 155,326 totalExercise: $0.76From: 2018-04-17Exp: 2027-05-17→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $10.71 to $10.87 per share. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- [F2]The stock option vests and becomes exercisable with respect to 25% of the total number of shares on April 17, 2018. The remaining shares vest and become exercisable in equal monthly installments over the following 36 months.